OPKO Health
OPK
#5819
Rank
A$1.63 B
Marketcap
A$2.06
Share price
0.74%
Change (1 day)
-16.04%
Change (1 year)

P/E ratio for OPKO Health (OPK)

P/E ratio as of December 2025 (TTM): -5.58

According to OPKO Health 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -5.58333. At the end of 2024 the company had a P/E ratio of -21.0.

P/E ratio history for OPKO Health from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-21.0247.68%
2023-6.04112.61%
2022-2.84-97.05%
2021-96.2-221.77%
202079.0-2948.3%
2019-2.77-75.12%
2018-11.120.58%
2017-9.25-96.02%
2016-233101.42%
2015-115362.19%
2014-25.0

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
19.6-451.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
15.3-373.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
16.5-395.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
46.4-930.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Alnylam Pharmaceuticals
ALNY
> 1000-81,700.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
17.2-408.67%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
25.4-555.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-25.3 352.82%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.